CDKN2A and squamous cell carcinoma: The frequency of CDKN2A deletion in squamous cell carcinoma combined with other components was significantly higher than that in pure squamous cell carcinoma (66.7% vs. 19.9%, P = 0.026) (Supplementary Table S4).